CORC

在结果中检索

CORC

浏览/检索结果: 共25条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report 期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 1
作者:  Cai, Yangyang;  Wang, Xu;  Guo, Ye;  Sun, Chao;  Xu, Yinghui
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05
Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung 会议论文
作者:  Goss, G.;  Cobo, M.;  Lu, S.;  Syrigos, K.;  Lee, K. H.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Afatinib versus erlotinib as second-line treatment of patients (pts) with advanced lung squamous cell carcinoma (SCC): Final analysis of the global phase III LUX-Lung 8 (LL8) trial 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29
作者:  Cseh, A.;  Felip, E.;  Bender, S.;  Goss, G. D.;  Cobo, M.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 9
作者:  Goss, Glenwood D.;  Felip, Enriqueta;  Cobo, Manuel;  Lu, Shun;  Syrigos, Konstantinos
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Lu, Shun;  Wu, Yi-Long;  Huang, Yunchao;  Hu, Cheng-Ping;  Li, Wei
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Zhang, Li;  Cseh, Agnieszka;  Peil, Barbara;  Wang, Jie;  Feng, Jifeng
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 11
作者:  Goss, G.;  Felip, E.;  Cobo, M.;  Lu, S.;  Syrigos, K.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders 会议论文
作者:  Li, W.;  Gadgeel, S. M.;  Soria, J. C.;  Felip, E.;  Cobo, M.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders 期刊论文
EUROPEAN JOURNAL OF CANCER, 2017, 卷号: 72
作者:  Goss, G.;  Cobo, M.;  Lu, S.;  Soria, J. C.;  Syrigos, K.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Second-Line Afatinib versus Erlotinib for Patients with Squamous Cell Carcinoma of the Lung (LUX-Lung 8): Analysis of Tumor and Serum Biomarkers 会议论文
作者:  Isla, Dolores;  Min, Young Joo;  Ardizzoni, Andrea;  Gadgeel, Shirish;  Dupuis, Nicholas
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace